Cholinergic function plays a role in a variant of context fear conditioning known as the context preexposure facilitation effect (CPFE; Robinson-Drummer, Dokovna, Heroux, & Stanton, 2016) . In the CPFE, acquisition of a context representation, the context-shock association, and expression of context fear occur across successive phases, usually 24 h apart. Systemic administration of scopolamine, a muscarinic acetylcholine receptor antagonist, prior to each phase (context preexposure, immediate-shock training, and testing) disrupts the CPFE in juvenile rats . Dorsal hippocampal (dHPC) cholinergic function contributes significantly to this effect, as local infusion of scopolamine into the dHPC prior to any individual phase of the CPFE produces a disruption identical to systemic administration . The current experiment extended these findings to another forebrain region implicated in the CPFE, the medial prefrontal cortex (mPFC). Adolescent rats received bilateral infusions of scopolamine (35 lg/side) or PBS 10 min before all three phases of the CPFE or only prior to a single phase. Intra-mPFC administration of scopolamine prior to all three phases significantly impaired fear conditioning suggesting that mPFC cholinergic function is necessary for successful CPFE performance. Analyses of the individual infusion days revealed a significant impairment of the CPFE when infusions occurred prior to preexposure or training (i.e. immediate footshock) but not prior to testing. In total, these findings suggests a role of mPFC cholinergic function in the acquisition and/or consolidation of a contextual representation and the context-shock association but not in retrieval or expression of fear memory. Implications for mPFC involvement in contextual fear conditioning and neurological dysfunction following neonatal alcohol exposure are discussed.
Introduction
Cholinergic function is crucial for performance of several forms of Pavlovian conditioning. Scopolamine, a muscarinic acetylcholine (mACh) receptor antagonist, administered during training can disrupt standard contextual fear conditioning (sCFC) to a background context (Anagnostaras, Maren, & Fanselow, 1995; Anagnostaras, Maren, Sage, Goodrich, & Fanselow, 1999; Gale, Anagnostaras, & Fanselow, 2001 ) as well as conditioning to a discrete cue (however see Hunt & Richardson, 2007) . In addition, a variant of sCFC known as the context preexposure facilitation effect (CPFE; Fanselow, 1990) has been used to specify the particular psychological processes affected by cholinergic antagonism during fear conditioning (Brown, Kennard, Sherer, Comalli, & Woodruff-Pak, 2011; Chang & Liang, 2012; Robinson-Drummer, Dokovna, Heroux, & Stanton, 2016) . During the CPFE, learning about the context (preexposure), context-shock association (training), and retrieval and expression of the context-fear memory (testing) occur across three separate days. Relative to sCFC, the temporal separation of the learning experiences during the CPFE make it well suited to separately analyze the mechanisms of context learning vs. context-shock learning as determinants of conditioned fear performance.
Similar to sCFC, performance of the CPFE is significantly impaired by antagonizing cholinergic receptors. Prior to conditioning on any single phase of the CPFE, both systemic and intrahippocampal scopolamine administration disrupts testing day performance (Brown et al., 2011; Robinson-Drummer et al., 2016) . Furthermore, post-shock (but not post-preexposure) intrahippocampal infusions of scopolamine significantly impairs CPFE performance (Chang & Liang, 2012) . These results support previous reports that the hippocampus is critical for contextual conditioning during the CPFE (Matus-Amat, Higgins, Barrientos, & Rudy, 2004; Matus-Amat, Higgins, Sprunger, Wright-Hardesty, & Rudy, 2007) and extend those results by suggesting a specific role of the hippocampal cholinergic system in contextual conditioning using the CPFE. Although most CPFE research has focused on this region, the hippocampus is not the singular target of cholinergic projections, so other brain regions receiving these projections may also play a role in the CPFE.
The medial prefrontal cortex (mPFC) is involved in the top down control of cognitive function (Dalley, Cardinal, & Robbins, 2004) , in systems consolidation, and in behavioral expression of context conditioning (Frankland & Bontempi, 2005; Wiltgen & Tanaka, 2013) . However, recently its role has been extended to include the initial acquisition of context memories (for review see Giustino & Maren, 2015) . Following the training phase of the CPFE, the mPFC shows learning-related increases in immediate early gene expression in both adult (Chakraborty, Asok, Stanton, & Rosen, 2016) and developing rats (Asok, Schreiber, Jablonski, Rosen, & Stanton, 2013; Schreiber, Asok, Jablonski, Rosen, & Stanton, 2014 ) and after hippocampal lesions or inactivation, compensatory mechanisms in the mPFC subserve fear conditioning to contextual stimuli (Zelikowsky et al., 2013) . Additionally, the mPFC receives rich innervation from the basal forebrain cholinergic system (Henny & Jones, 2008) making it a likely contributor to the disruptive effects of cholinergic antagonism on contextual fear conditioning.
Although many studies have explored the importance of mPFC cholinergic function to attention and working memory (Broersen, Heinsbroek, de Bruin, Uylings, & Olivier, 1995; Chen, Baxter, & Rodefer, 2004; Chudasama, Dalley, Nathwani, Bouger, & Robbins, 2004; McGaughy, Ross, & Eichenbaum, 2008; Newman & McGaughy, 2008) , the neuromodulatory role of the mPFC cholinergic system in (contextual) fear conditioning is largely unexplored. The current study investigated the effect of intra-mPFC antagonism of cholinergic function during all three conditioning phases of the CPFE in 31-day-old rats, a period that marks the transition from juvenile to adolescent stages of development (Spear, 2000) . In Experiment 1, scopolamine was administered prior to all three phases of the CPFE to broadly implicate the mPFC cholinergic system in the CPFE. Experiments 2-4 each examined cholinergic antagonism on only a single day of the CPFE (i.e. preexposure, training or testing day only) in order to more precisely identify the psychological processes that may be impaired by mPFC scopolamine infusions. Results of the current study support a role for the mPFC cholinergic system in context learning and context-shock association but not retrieval or expression of context fear.
General methods

Subjects
Time-mated females were housed with breeder males overnight and were examined for an ejaculatory plug the following day and, if found, that day was designated as gestational day (GD) 0. Dams were housed in clear polypropylene cages measuring 45 Â 24 Â 21 cm with standard bedding and access to ad libitum water and rat chow. Animals were maintained on a 12:12 h light/-dark cycle with lights on at 7:00 am. Date of birth (GD22) was designated as postnatal day (PD) 0. Litters were culled on PD3 to eight pups (usually 4 males and 4 females) and were paw-marked with subcutaneous injections of non-toxic black ink for identification. Pups were weaned from their mother on PD21 and housed with same-sex litter mates in 45 Â 24 Â 17 cm cages. On PD29 animals were individually housed in small white polypropylene cages (24 Â 18 Â 13 cm) with ad libitum access to water and rat chow for the remainder of the experiment. All subjects were treated in accordance with a protocol approved by the Institutional Animal Care and Use Committee at the University of Delaware following guidelines established by the National Institute of Health.
Apparatus and stimuli
Fear conditioning occurred in four clear Plexiglas chambers designated as Context A as described previously (Heroux, RobinsonDrummer, Rosen, & Stanton, 2016; Murawski & Stanton, 2010; Robinson-Drummer et al., 2016) . The chambers measured 16.5 Â 12.1 Â 21.6 cm and were arranged in a 2 Â 2 formation on a Plexiglas stand within a fume hood which provided ambient light and background noise. Each chamber had a grid floor made of 9 stainless steel bars, 0.5 cm in diameter and spaced 1.25 cm apart. The unconditioned stimulus (US), two 1.5 mA, 2 s foot shocks, was delivered using a shock scrambler (Med Associates, Georgia, VT ENV-414S) connected to the grid floor. Video of each session (preexposure, training, testing) was recorded using FreezeFrame software (Actimetrics, Wilmette IL), which measures change in pixilation, with freezing defined as a bout of 0.75 s or longer without a change in pixels. The FreezeFrame software recorded video from the four chambers simultaneously. Context B consisted of the same Plexiglas chambers used in Context A with modifications, which have been described previously (Asok et al., 2013; Murawski & Stanton, 2010; Robinson-Drummer et al., 2016; Schreiber et al., 2014) . Wire mesh inserts, which protruded into the chambers, changed both the texture of the floor and the dimensions of the chamber. In addition, white opaque coverings were added such that only the wall facing the camera remained unobscured.
Surgery
On PD29, juvenile rats were taken from post-weaning group housing and anesthetized with an i.p. ketamine/xylazine injection and subcutaneous buprenorphine near the incision site to reduce post-operative discomfort. A fused double-guide cannula (Plastics One, Roanoke, VA) was implanted bilaterally to terminate above the prelimbic region of medial prefrontal cortex using the following coordinates: anteroposterior (AP) +9.0 mm and mediolateral (ML) ±0.6 mm relative to interaural midline and dorsoventral (DV) À2.3 mm relative to the top of the skull. Cannula were fixed in placed using dental acrylic and curved ''skull hooks" (Schiffino, Murawski, Rosen, & Stanton, 2011; Watson & Stanton, 2009 ). Following surgery, dummy internals and dust caps were inserted in the guide cannula to reduce occlusion of the guide cannula and rats were allowed to recover in individual white cages with electric heating pads placed under half of the cage floor. Animals were allowed to recover for approximately 24 h until their cannulas were cleared the following day. For each animal, 0.25 lL of the vehicle phosphate buffered saline (PBS; Fisher Scientific, Waltham, MA) was infused per side to ensure that no cannulas were occluded.
Drug infusion
Depending on their drug condition (see Sections 2.5 and 2.6) rats received microinjections of either PBS or scopolamine hydrobromide (Scop; Sigma Aldrich, St. Louis, MO) dissolved in PBS approximately ten minutes before behavioral training. Animals were hand held while scopolamine (140 lg/lL dissolved in PBS) was infused at a rate of 0.25 lL per minute for a single minute, administering 35 lg of scopolamine per side per animal. This dose has been used previously in our lab (Brito, Davis, Stopp, & Stanton, 1983; Robinson-Drummer et al., 2016) and similar doses of scopolamine have been infused intra-cranially in other labs (Chang & Liang, 2012; Gale et al., 2001; Rogers & Kesner, 2004) . Drug injectors were left in place for an additional minute to allow diffusion of drug before removal. PBS control animals were administered the same volume of PBS at the same rate as scopolamine animals. A 0.25 lL infusion diffuses about 1 mm from the cannula tip ensur-ing that the spread of the drug is restricted to the prefrontal cortex. This is based on our other studies using injected dyes (Jablonski, Watson, & Stanton, 2010) or labelled muscimol (Heroux, Robinson-Drummer, Sanders, Rosen, & Stanton, in preparation) . After infusions, animal were returned to their home cage until conditioning.
Behavioral procedure
Behavioral training occurred over three days from PD31-33 (±1d) using the previously described multiple preexposure procedure (Dokovna, Jablonski, & Stanton, 2013; Robinson-Drummer et al., 2016) . On the preexposure day, (PD31) pups were weighed, and then placed in transport boxes of clear Lexan (11 Â 11 Â 18 cm) covered with orange construction paper to obscure visual cues during transport. Rats were brought in sets of 4 to the hallway immediately adjacent to the training room while the chambers were cleaned with 5% ammonium hydroxide solution. Each rat was placed in its designated chamber and allowed to explore the context for 5 min. They were then removed, and placed back in their respective transport boxes for approximately 1 min, brought back over and placed in the chamber for a 1 min exposure. This was repeated 4 times for a total of five 1-min exposures. Animals were then removed and returned to their home cage, ending the preexposure session. Pre group animals were exposed to the Context A chamber configuration while a second group of animals were treated identically to the Pre group however the chambers were arranged in the Context B configuration (see Section 2.2) and comprised the alternate exposure condition (Alt-Pre group).
On PD32, animals from all groups were trained in Context A. Weighing, transport and chamber cleaning was identical to that performed on the preexposure day. Rats were brought from the waiting area one at a time, placed in their respective training chamber, and received two immediate (<5 s) 1.5 mA, 2 s foot shock separated by one second. Animals were immediately removed from the chamber following the foot shock, returned to their transport cages and, following training of the last animal, all 4 animals were taken back to their home cages.
Testing occurred 24 h following training in Context A. Weighing, transport and chamber cleaning was identical to that performed on the preexposure and training days. All animals were returned to the chambers in which they were trained 24 h earlier and tested, for 5 min, under identical circumstances as previously described for preexposure (in Context A).
Experimental design
For all studies, animals were randomly assigned to receive either PBS or Scop prior to behavioral conditioning on either all three days of training (Experiment 1) or prior to only the preexposure (Experiment 2), training (Experiment 3) or testing day (Experiment 4). Pre group animals were split between drug (PBS or Scop) and infusion day (all days, pre-only, training-only or test-only) while the Alt-Pre group was pooled across drug (except where noted). The Alt-Pre group has historically performed similarly regardless of drug treatment (Dokovna et al., 2013; Jablonski, Schiffino, & Stanton, 2012; Robinson-Drummer et al., 2016; Schiffino et al., 2011) and pooling reduces the number of animals needed for completion of the study. Sex was counterbalanced within litters for each preexposure, drug and infusion day group and was collapsed within an experimental group (except where noted).
Data & statistical analysis
Data and statistical analyses were as described previously (Murawski & Stanton, 2010; Robinson-Drummer et al., 2016) . All collected data were analyzed using FreezeFrame software (Acimetrics, Wilmette IL) with a bout of freezing (the cessation of all movement except breathing) set to 0.75 s. The software program computes a ''motion index" that was adjusted to set a freezing threshold separately for each animal (per software instructions) by a blind observer who verified from the video record that small movements were not recorded as freezing. Once set, the threshold did not change during a session. We have validated this procedure against other scoring methods (e.g., hand scoring of video records by blind observers) and found that it is very reliable (r = 0.976; p < 0.01; unpublished observations). Freezing behavior was scored as the total percent time spent freezing over a 5 min testing session. Animal data was imported into Statistica 10 data analysis software. Statistical significance was set to p < 0.05. Outliers were removed from test day freezing scores to reduce statistical variability. They were defined a priori as having a score ±1.96 standard deviations from the mean of all other rats in their respective groups. The typical outlier greatly exceeded the 1.96 threshold. Across this entire study, the mean (±SE) outlier z-score value was 3.39 (±0.58). Planned comparisons and post hoc Neuman-Keuls tests were used to assess any significant effects revealed by ANOVA.
Experiment 1
mPFC muscarinic cholinergic function is necessary for successful performance of the CPFE (Fig. 2) .
Methods and results
The current experiment administered 0.25 lL vehicle PBS or 35 lg scopolamine into the mPFC (see Sections 2.3 and 2.4) 10 min prior to all three phases of the CPFE (i.e. preexposure, training and testing). Thirty-five Long-Evans rats from 22 litters were assigned to groups by drug (PBS v Scop) and preexposure condition (Pre v Alt-Pre) with testing day freezing being statistically compared across groups. There was no effect of drug observed in the Alt-Pre group [F(1, 9) = 2.10, p = 0.18] so this variable was pooled across drug. Four subjects were removed due to misplaced cannula (Pre PBS n = 1, Pre Scop n = 3; .32] so all analyses were collapsed across this variable. Subsequent analyses are the result of a three group one-way ANOVA (Pooled Alt-Pre, Pre Scop, and Pre PBS). A single outlier was removed from each of the three experimental groups and final group sizes were as follows: Pooled Alt-Pre n = 11, Pre Scop n = 8, and Pre PBS n = 9. ANOVA revealed a significant effect of condition [F(1, 25) = 22.26, p < 0.001] such that freezing in the Pre PBS group was significantly elevated above both Pre Scop and Pooled Alt-Pre (p's < 0.001) however there was no difference between Pre Scop and Alt-Pre (p = 0.75), indicating that the drug abolished the CPFE. These results suggest a significant role for mPFC cholinergic function in successful performance of the CPFE but they do not indicate whether a particular phase of the CPFE is critical for this effect.
Experiment 2
Scopolamine infusions into the mPFC prior to the Preexposure day impairs contextual learning during the CPFE (Fig. 4) .
Methods and Results
To examine prefrontal cholinergic involvement in context learning, intra-mPFC infusions of scopolamine for the current experiment were administered only prior to the preexposure day of the CPFE. Forty-one rats from 26 litters were grouped by drug (PBS v Scop) and preexposure condition (Pre v Alt-Pre). Four animals were removed from analyses due to misplaced cannula ( Fig. 3 ; Alt-Pre Scop n = 1, Pre PBS n = 2, Pre Scop n = 1). Again, lack of Sex [F(1, 35) = 0.67, p = 0.42] or Sex Â Condition interaction [F (2, 35) = 2.32, p = 0.11] effect led us to pool subsequent analyses across this factor. There was a significant effect of drug in the Alt-Pre group [F(1, 11) = 30.60, p < 0.001] so pooling across drug was not possible in this experiment. A single outlier was removed from Alt-Pre PBS, Alt-Pre Scop and Pre Scop groups and two outliers were removed from Pre PBS group. Final group sizes were as follows: Alt-Pre PBS n = 7, Alt-Pre Scop n = 6, Pre PBS n = 16, Pre Scop n = 12. The four experimental conditions were analyzed using ANOVA and planned comparisons. ANOVA revealed a significant effect of condition [F(3, 37 These results indicate that muscarinic-type cholinergic function is necessary for context learning (or possibly consolidation of this learning) on the preexposure day of the CPFE.
Experiment 3
Training day processes are significantly impaired by mPFC muscarinic antagonism during the CPFE (Fig. 6) . 
Methods and results
To examine prefrontal cholinergic involvement in contextshock learning, scopolamine was infused bilaterally into the mPFC only prior to immediate foot shock (two 2 s, 1.5 mA) training. Forty Long-Evans rats from 26 litters were grouped by drug (PBS v Scop) and preexposure condition (Pre v Alt-Pre). Three animals were removed from analyses due to misplaced cannula ( Fig. 5 ; Alt-Pre Scop n = 1, Pre PBS n = 1, Pre Scop n = 1). There was no effect of drug in the Alt-Pre groups [F(1, 11) = 1.32, p = 0.27] so a Pooled Alt-Pre group was used. Data were also pooled across sex because a 2 (Sex: Male, Female) Â 3 (Condition: Pooled Alt-Pre, Pre PBS, Pre Scop) ANOVA revealed no main effect [F(1, 29) = 0.27, p = 0.61] or interaction [F(2, 29) = 0.08, p = 0.93] involving this factor. A single outlier was removed from each of the three experimental groups and final group sizes were as follows: Pooled Alt-Pre n = 13, Pre Scop n = 12, and Pre PBS n = 10. A three group one-way ANOVA (Pooled Alt-Pre, Pre Scop, and Pre PBS) revealed a significant effect of condition [F(1, 32) = 18.27, p < 0.001] such that Pre PBS was significantly elevated above both Pre Scop and Pooled Alt-Pre (p's < 0.001) however there was no difference between Pre Scop and Pooled Alt-Pre (p = 0.54). These results suggest that mPFC muscarinic activity is necessary for training-day processes during the CPFE.
Experiment 4
Intra-mPFC Scopolamine does not affect fear memory retrieval or performance of the CPFE when administered prior to testing (Fig. 8) .
Methods and results
The current experiment infused scopolamine into the mPFC prior to fear memory testing to examine effects on retrieval or expression of the CPFE. Forty-three rats from 21 litters were grouped by drug (PBS v Scop) and preexposure condition (Pre v Alt-Pre). Six animals were removed due to misplaced cannula ( Fig. 7 ; Alt-Pre PBS n = 2, Pre PBS n = 1, Pre Scop n = 3). Alt-Pre groups were unaffected by drug [F(1, 10) = 0.004, p = 0.95] so a Pooled Alt-Pre group was used. Although 2 (Sex: Male, The interaction was driven by a significant difference between female and male animals in the Pre Scop group (p = 0.01) so there were no subsequent analyses that pooled across this variable. One outlier was removed from each of the six groups. Group sizes were as follows: Female Pooled Alt-Pre n = 5, Female Pre PBS n = 5, Female-Pre Scop n = 6, Male Pooled Alt-Pre n = 7, Male Pre PBS n = 8, Male-Pre Scop n = 9. Newman-Keuls post hoc tests revealed that in males, there was no significant difference observed between Pre Scop and Pre PBS (p = 0.94) and a significant CPFE was evident regardless of testing day drug (ps < 0.05 relative to Pooled Alt-Pre). However, in females the significant CPFE observed between Pre PBS and Pooled Alt-Pre (p < 0.001) was not evident between Pre Scop and Pooled Alt-Pre (p = 0.81). This evidence that mPFC scopolamine influences expression of the CPFE in females but not males should be regarded with caution as it may reflect sampling error. Analysis of effect sizes indicates that twice as much of the variance results from the drug condition (g p 2 = 0.462) than the sex Â drug condition interaction (g p 2 = 0.241) and nearly none of the variance is due to sex alone (g p 2 = 0.003). We have also not seen similar sex differences following systemic or intra-hippocampal scopolamine administration . On the other hand, there is some evidence that the mPFC may contribute to sex differences observed in eyeblink conditioning following stress (Maeng & Shors, 2013; Maeng, Waddell, & Shors, 2010; Wood & Shors, 1998) . Whether the present findings represent this type of outcome or are merely sampling error is a question that requires further study.
Discussion
The current experiments demonstrate a necessary role of muscarinic cholinergic receptor function in the medial prefrontal cortex in the CPFE. This system contributes to learning-related activity on the preexposure (Experiment 2) and training (Experiment 3) days but not to memory retrieval or CPFE performance on the testing day (Experiment 4), at least in males. The effects observed in Experiments 2 and 3 are unlikely to be statedependent as the animals were able to express fear during testing while on the drug. Furthermore, a state-dependent account of the current results predicts that there would be no effect of the scopolamine when the drug is given during all three phases of the CPFE, a prediction that was not supported by the outcome of Experiment 1.
The results of Experiments 2 and 3 support and extend previous reports of a role of the mPFC in the acquisition of contextual fear conditioning. Acquisition of background contextual conditioning (i.e. when the context is not the sole predictor of the US) is significantly impaired by disrupting neural activity or plasticity in the mPFC prior to conditioning (Gilmartin & Helmstetter, 2010; Gilmartin, Kwapis, & Helmstetter, 2013) . However, the cooccurrence of context learning and context-shock association during sCFC in these previous studies makes it difficult to parse out which psychological process is affected by disruption of mPFC function. The current results extend previous knowledge by suggesting a necessary role for cholinergic mPFC function for acquisition of both the context representation and the context-shock association. Intra-hippocampal scopolamine significantly impairs CPFE performance when infused post-training while postpreexposure infusions have no effect suggesting a consolidation deficit on the training day and an encoding deficit on the preexposure day (Chang & Liang, 2012) . Other results from our lab (Heroux et al., in preparation) also suggest that the current training day effects may reflect a consolidation (or reconsolidation) effect. Pre-training mPFC inactivation spares post-shock freezing, suggesting inactivation does not prevent rats from retrieving the context representation and momentarily associating it with a foot shock. Furthermore, if scopolamine targets consolidation processes, post-conditioning infusions should have the same effect on CPFE performance as the current experiments. Although this has been reported following intra-hippocampal scopolamine (Chang & Liang, 2012) , additional experimentation is necessary to dissociate the effect of mPFC scopolamine on acquisition versus consolidation of contextual fear conditioning. The lack of a deficit following pre-testing scopolamine in Experiment 4 was surprising as the mPFC (specifically the prelimbic region) is thought to be the primary region responsible for fear expression (Giustino & Maren, 2015) . Whereas the current results suggest no contribution of the mPFC cholinergic system to testingday processes, previous results do demonstrate a need for a functional mPFC either for memory retrieval or expression of contextual fear (Corcoran & Quirk, 2007; Heroux et al., in preparation) . In their review, Giustino and Maren (2015) suggest that the mPFC is differentially recruited for fear memory acquisition or expression depending on the task requirements. However they do not speculate on the mechanism by which this task-dependent recruitment is achieved. It is likely that this recruitment is dependent on circuit-level interactions of the mPFC with other regions necessary for contextual conditioning. Prefrontal inhibition during contextual fear conditioning disrupts entorhinal-hippocampal activity and these circuit-level changes are associated with reduced fear memory during testing 24 h later (Bero et al., 2014) . Additionally, in a model of mPFC regulation of attention, the ability for the mPFC to switch cue-processing modes depends on both tonic and transient cholinergic function from the basal forebrain (BF; Hasselmo & Sarter, 2011) . Tonic BF cholinergic activity regulates cueevoked glutamatergic input from thalamic nuclei that in turn may modulate transient cholinergic changes from projections that enhance cue detection. Taken together, testing day exposure to the training context may not trigger (contextual) cue-related mAChrtype mPFC activity, either directly or through afferent projections from other regions. Whether these types of circuit-and transmitter-level neuromodulations are acting to control mPFC involvement in the CPFE across the different phases is an interesting question to be explored in future studies.
Several neurotransmitter systems have been identified, across the contextual fear circuit, as being crucial for conditioning however their roles vary by region and phase of conditioning. In the hippocampus, both muscimol (GABA A agonist) and scopolamine (muscarinic cholinergic antagonist) impair the CPFE when administered prior to any single phase of the CPFE protocol (Matus-Amat et al., 2004; Robinson-Drummer et al., 2016) . However, intrahippocampal NMDA-type glutamate antagonists only impair the CPFE when they are administered prior to preexposure (MatusAmat et al., 2007; Schiffino et al., 2011) . In the amygdala, APV (NMDA-type glutamate antagonist) significantly impairs CPFE performance when administered prior to immediate shock training but not prior to preexposure or testing (Matus-Amat et al., 2007) . In these regions, as well as the mPFC, afferent connections from other regions and the distribution of neurotransmitter receptors on pre-and post-synaptic neuronal projections likely give rise to the specialized function of that region during the particular CPFE phases. Specifically how these neurotransmitter systems, both singularly and in concert, contribute to specific prefrontal mnemonic functions (e.g. context learning vs. context-shock association) during the CPFE is a fruitful direction for future research.
The CPFE emerges between 2 and 3 weeks postnatally and does not develop further behaviorally between adolescence and adulthood (Jablonski et al., 2012; Robinson-Drummer & Stanton, 2015; Schiffino et al., 2011) . However, the current report does not include a comparison with adults so it is possible that there is a differential involvement of the mPFC in fear conditioning in the CPFE between adolescence and adulthood. The mPFC likely performs a similar role in acquisition of contextual fear conditioning but may play a different role during long-term memory between adolescence and adulthood. Adults and adolescent rats show similar learningrelated changes in mPFC gene expression during the CPFE (Asok et al., 2013; Chakraborty et al., 2016; Schreiber et al., 2014 ) and the mPFC is involved in context conditioning in adults rats (Zelikowsky et al., 2013; Zelikowsky, Hersman, Chawla, Barnes, & Fanselow, 2014) . However, long-term retention of context learning changes between adolescence and adulthood. Adult rats can retain memory of a context for at least 3 weeks (Robinson-Drummer & Stanton, 2015; Rudy & Wright-Hardesty, 2005 ) however adolescent rats can only remember contexts for two weeks (RobinsonDrummer & Stanton, 2015) . It is possible that the remaining maturation in the prefrontal cortex observed between adolescence and adulthood (Coyle & Yamamura, 1976; Ferguson & Gao, 2014; Lee, Nicklaus, Manning, & Wolfe, 1990; Van Eden & Uylings, 1985) contributes not to the initial acquisition of contextual learning but to the long-term consolidation of previously acquired memory (Frankland & Bontempi, 2005; Wiltgen & Tanaka, 2013) . This is an interesting and understudied area in ontogeny of memory that should be explored in future reports.
The significant impairment in CPFE performance observed following cholinergic antagonism in the mPFC may be relevant to behavioral impairments in fetal alcohol spectrum disorder (FASD). Cholinergic dysfunction has been implicated in learning-related impairments in FASD in humans and rodent models (Fryer et al., 2007; Jacobson et al., 2008; Lebel, Roussotte, & Sowell, 2011; Lewis et al., 2015; Malisza et al., 2005; Mattson, Crocker, & Nguyen, 2011; Murawski, Moore, Thomas, & Riley, 2015; Rasmussen, 2005) . Converging evidence from these studies implicate, in addition to the hippocampus, significant impairments in prefrontal structure and function. The CPFE is disrupted by neonatal alcohol exposure (Hamilton et al., 2011; Murawski & Stanton, 2010 and this impairment is rescued by enhancement of cholinergic function (Dokovna et al., 2013) . Furthermore, alcohol-induced behavioral and mnemonic impairments as well as molecular changes in the hippocampus and prefrontal cortex can be rescued with cholinergic supplementation (Monk, Leslie, & Thomas, 2012; Otero, Thomas, Saski, Xia, & Kelly, 2012; Schneider & Thomas, 2016; Thomas, Biane, O'Bryan, O'Neill, & Dominguez, 2007; Thomas, Idrus, Monk, & Dominguez, 2010; Thomas & Tran, 2012; Wagner & Hunt, 2006) . Taken together, these studies and the results of the current report support a potential role of prefrontal cholinergic dysfunction in learning and memory impairment in FASD that should be more directly explored in future experiments.
Based on the accumulated literature from our lab and others that use the CPFE, both the mPFC and dHPC play significant and varied roles during all three CPFE phases. This developing knowledge of contextual fear conditioning challenges previous models of system consolidation that suggest separate roles for the dHPC and mPFC in recent and remote memories, respectively (Frankland & Bontempi, 2005; Quinn, Ma, Tinsley, Koch, & Fanselow, 2008) . The current report shows that the role of mPFC is not confined to remote memory. Rather, it is likely a site of early acquisition and consolidation of fear memories as well as a participant in the long term retrieval and expression of that memory (Giustino & Maren, 2015; Heroux et al., in preparation) . Additionally, mPFC activity (as measured by relative gene expression) during the CPFE not only changes during context exposure but increases in a learning-related way following immediate shock training (Asok et al., 2013; Schreiber et al., 2014) . It seems that as new contextual conditioning parameters are explored many of the canonical models of mPFC contributions to contextual fear memory will need to be revised to include a role of the mPFC in the early acquisition, encoding and consolidation of memories.
Taken together, our lab has demonstrated that the mPFC contributes to the early stages of contextual fear conditioning during the CPFE (Heroux et al., in preparation) and that the cholinergic system in the mPFC contributes to acquisition or consolidation of context-and context-shock learning but not retrieval or expression of this learning during the test phase of the CPFE. These findings encourage further, more nuanced exploration of mPFC involvement in the early stages of contextual fear conditioning and neurobehavioral deficits following neonatal alcohol exposure.
